The Future of Colorectal Cancer Screening: Reaching the Unscreened
About this episode
Dr. AmirAli Talasaz discusses blood-based screening for colorectal cancer and its potential to reach unscreened patients.
In this episode, Dr. AmirAli Talasaz, Co-Founder and Co-CEO of Guardant Health, discusses how blood-based screening can help close persistent colorectal cancer screening gaps and reach millions of unscreened patients. He also explores how the Shield Blood Test can increase screening participation, reconnect unscreened patients with health systems and enable earlier detection of colorectal cancer, particularly in rural and underserved communities. This episode is sponsored by Guardant Health .
People in this episode
Guest: Dr. AmirAli Talasaz
Topics covered
- colorectal cancer screening
- blood-based screening
- health systems
- early detection
- rural communities
- underserved populations
Sponsors
Guardant Health
More episodes of Becker’s Healthcare Podcast
- The Growing Trend of AI Agents in the Health System & What Leaders Can Do to Keep Operations Secure
- Dr. Anthony Andre on Human Factors, AI and Designing Safer Healthcare Technology
- Austin Willuweit on Rural Health Finance, Growth and AI
- Katrina Ascencio-Holmes on Building and Retaining Sutter Health’s Nursing Workforce
- Building Trustworthy AI in Healthcare Through Transparency
- Dr. John Whyte on AI, Wearables and the Future of Medical Education
Explore listener stats, chart rankings, contacts and more on the Becker’s Healthcare Podcast podcast page.